Literature DB >> 6528942

Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.

K Jimbow, H Takahashi, S Miura, S Ikeda, A Kukita.   

Abstract

This study, based on 67 Japanese cases of acral malignant melanomas, presents their gross clinical and histologic features and the natural history of the lesions with respect to anatomic locations, thicknesses, and sex of patients afflicted. We found that the anatomic locations of malignant melanomas in Japanese are unique in the sense that more than 40% of cutaneous melanomas occurred in palmoplantar and subungual sites, about 80% showed the clinical and histologic features of the acral lentiginous type, 15% were in the form of nodular malignant melanoma, and 3% in the form of superficial spreading malignant melanoma. We did not find any difference in prognosis of acral malignant melanomas from that of malignant melanomas on other parts of the body. Neither was there significant difference in the overall survival rates or in the survival rates within same range of thickness. There was some difference in the survival rates of patients with palmoplantar and subungual malignant melanoma of men and women, the women being younger and having better survival rates than the men. However, no significant difference was found in survival rates from the factor of thickness of lesion. Our study indicates the usefulness of specifications of thickness and anatomic site in predicting biological behavior and natural course of acral malignant melanomas.

Entities:  

Mesh:

Year:  1984        PMID: 6528942

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  5 in total

1.  Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

Authors:  Priyanka V Gumaste; Nathaniel H Fleming; Ines Silva; Richard L Shapiro; Russell S Berman; Judy Zhong; Iman Osman; Jennifer A Stein
Journal:  J Natl Compr Canc Netw       Date:  2014-12       Impact factor: 11.908

2.  Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.

Authors:  Porcia T Bradford; Alisa M Goldstein; Mary L McMaster; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2009-04

Review 3.  NUAK2: an emerging acral melanoma oncogene.

Authors:  Takeshi Namiki; Sergio G Coelho; Vincent J Hearing
Journal:  Oncotarget       Date:  2011-09

4.  Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.

Authors:  Yasuhiro Fujisawa; Shusuke Yoshikawa; Akane Minagawa; Tatsuya Takenouchi; Kenji Yokota; Hiroshi Uchi; Naoki Noma; Yasuhiro Nakamura; Jun Asai; Junji Kato; Susumu Fujiwara; Satoshi Fukushima; Jiro Uehara; Toshihiko Hoashi; Tatsuya Kaji; Taku Fujimura; Kenjiro Namikawa; Manabu Yoshioka; Naoki Murao; Dai Ogata; Kanako Matsuyama; Naohito Hatta; Yoshitsugu Shibayama; Toshiharu Fujiyama; Masashi Ishikawa; Daisuke Yamada; Akiko Kishi; Yoshiyuki Nakamura; Takatoshi Shimiauchi; Kazuyasu Fujii; Manabu Fujimoto; Hironobu Ihn; Norito Katoh
Journal:  Cancer Med       Date:  2019-04-01       Impact factor: 4.452

5.  Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.

Authors:  Shelly X Bian; Lindsay Hwang; Jennifer Hwang; Omar Ragab; Gino K In; David Peng; Eugene Lin
Journal:  Pigment Cell Melanoma Res       Date:  2021-08-02       Impact factor: 4.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.